| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Jul 13, 2026 |
Merck & Co Inc
MRK
|
BUY |
$145.00
Est. +17%
|
$123.54 | $131.74 |
Pending
|
$127.52
+3.2%
|
| Jul 08, 2026 |
Vera Therapeutics Inc - Ordinary Shares - Class A
VERA
|
BUY |
$76.00
Est. +77%
|
$42.96 | $43.69 |
Pending
|
$36.06
-16.1%
|
| Jul 02, 2026 |
Alkermes plc
ALKS
|
BUY |
$65.00
Est. +26%
|
$51.72 | $55.67 |
Pending
|
$52.58
+1.7%
|
| Jun 26, 2026 |
Johnson & Johnson
JNJ
|
BUY |
$270.00
Est. +6%
|
$253.56 | $269.43 |
Bullseye Hit (±1%)
|
$255.63
+0.8%
|
| Jun 25, 2026 |
Travere Therapeutics Inc
TVTX
|
BUY |
$65.00
Est. +9%
|
$59.40 | $60.10 |
Pending
|
$56.26
-5.3%
|
| Jun 02, 2026 |
Merck & Co Inc
MRK
|
BUY |
$140.00
Est. +22%
|
$115.21 | $131.74 |
Pending
|
$127.52
+10.7%
|
| Jun 02, 2026 |
Jade Biosciences, Inc.
JBIO
|
BUY |
$47.00
Est. +153%
|
$18.59 | $23.49 |
Pending
|
$19.85
+6.8%
|
| May 08, 2026 |
Insmed Inc
INSM
|
BUY |
$226.00
Est. +115%
|
$105.00 | $122.94 |
Pending
|
$106.64
+1.6%
|
| Apr 10, 2026 |
Abbvie Inc
ABBV
|
BUY |
$249.00
Est. +18%
|
$210.15 | $261.64 |
Target Met
|
$253.30
+20.5%
|
| Jan 23, 2026 |
Johnson & Johnson
JNJ
|
BUY |
$240.00
Est. +10%
|
$218.49 | $269.43 |
Target Met
|
$255.63
+17.0%
|
| Jan 16, 2026 |
ANI Pharmaceuticals Inc
ANIP
|
BUY |
$124.00
Est. +45%
|
$85.29 | $87.76 |
Pending
|
$77.61
-9.0%
|
| Jan 14, 2026 |
Travere Therapeutics Inc
TVTX
|
BUY |
$49.00
Est. +73%
|
$28.39 | $60.10 |
Target Met
|
$56.26
+98.2%
|
| Dec 01, 2025 |
Evolus Inc
EOLS
|
BUY |
$19.00
Est. +179%
|
$6.82 | $7.34 |
Pending
|
$5.89
-13.6%
|
| Sep 08, 2025 |
ANI Pharmaceuticals Inc
ANIP
|
BUY |
$114.00
Est. +20%
|
$95.20 | $99.50 |
Pending
|
$77.61
-18.5%
|
| Jun 16, 2025 |
Jade Biosciences, Inc.
JBIO
|
BUY |
$14.00
Est. +107%
|
$6.76 | $27.96 |
Target Met
|
$19.85
+193.6%
|
| Mar 24, 2025 |
Valneva SE - ADR
VALN
|
BUY |
$15.00
Est. +102%
|
$7.43 | $12.25 |
Miss
|
$4.90
-34.1%
|
| Feb 03, 2025 |
Johnson & Johnson
JNJ
|
BUY |
$166.00
Est. +9%
|
$151.87 | $231.19 |
Target Met
|
$255.63
+68.3%
|
| Nov 13, 2024 |
Alkermes plc
ALKS
|
BUY |
$40.00
Est. +53%
|
$26.07 | $36.45 |
Miss
|
$52.58
+101.7%
|
| Oct 30, 2024 |
Sage Therapeutics Inc
SAGE
|
BUY |
$10.00
Est. +27%
|
$7.86 | $9.36 |
Miss
|
$8.68
+10.4%
|
| Sep 27, 2024 |
Travere Therapeutics Inc
TVTX
|
BUY |
$23.00
Est. +53%
|
$15.04 | $28.69 |
Target Met
|
$56.26
+274.1%
|
| Sep 23, 2024 |
Keros Therapeutics Inc
KROS
|
BUY |
$96.00
Est. +72%
|
$55.80 | $72.37 |
Miss
|
$10.21
-81.7%
|
| Sep 17, 2024 |
Revance Therapeutics Inc
RVNC
|
BUY |
$6.66
Est. +12%
|
$5.96 | $6.30 |
Miss
|
$3.65
-38.8%
|
| Sep 13, 2024 |
Evolus Inc
EOLS
|
BUY |
$25.00
Est. +52%
|
$16.46 | $17.82 |
Miss
|
$5.89
-64.2%
|
| Sep 09, 2024 |
Travere Therapeutics Inc
TVTX
|
BUY |
$25.00
Est. +296%
|
$6.31 | $25.29 |
Precision Hit (±3%)
|
$56.26
+791.6%
|
| Sep 09, 2024 |
ExlService Holdings Inc
EXLS
|
SELL |
$25.00
Est. +31%
|
$36.18 | $35.52 (Low) |
Miss
|
$26.83
+25.8%
|
| Jul 30, 2024 |
Pfizer Inc.
PFE
|
BUY |
$36.00
Est. +17%
|
$30.72 | $31.54 |
Miss
|
$24.83
-19.2%
|
| Jul 09, 2024 |
Insmed Inc
INSM
|
BUY |
$95.00
Est. +36%
|
$70.05 | $106.83 |
Target Met
|
$106.64
+52.2%
|
| Jun 27, 2024 |
Savara Inc
SVRA
|
BUY |
$10.00
Est. +421%
|
$1.92 | $5.11 |
Miss
|
$5.65
+194.3%
|
| May 10, 2024 |
Revance Therapeutics Inc
RVNC
|
BUY |
$8.00
Est. +114%
|
$3.73 | $6.65 |
Miss
|
$3.65
-2.1%
|
| Apr 17, 2024 |
Sage Therapeutics Inc
SAGE
|
BUY |
$20.00
Est. +65%
|
$12.11 | $13.46 |
Miss
|
$8.68
-28.3%
|
| Apr 11, 2024 |
GSK Plc - ADR
GSK
|
SELL |
$36.00
Est. +12%
|
$40.69 | $31.72 (Low) |
Target Met
|
$50.76
-24.7%
|
| Apr 09, 2024 |
Alkermes plc
ALKS
|
BUY |
$35.00
Est. +31%
|
$26.73 | $36.45 |
Target Met
|
$52.58
+96.7%
|
| Apr 09, 2024 |
Alpine Immune Sciences Inc
ALPN
|
BUY |
$55.00
Est. +43%
|
$38.53 | $65.00 |
Target Met
|
$64.97
+68.6%
|
| May 09, 2023 |
Abbvie Inc
ABBV
|
BUY |
$171.00
Est. +16%
|
$147.01 | - | - |
$253.30
+72.3%
|
| May 03, 2022 |
Lilly(Eli) & Co
LLY
|
BUY |
$356.00
Est. +23%
|
$289.56 | - | - |
$1,163.08
+301.7%
|
| May 02, 2022 |
Pfizer Inc.
PFE
|
BUY |
$55.00
Est. +12%
|
$49.07 | - | - |
$24.83
-49.4%
|
| Feb 06, 2022 |
Abbvie Inc
ABBV
|
BUY |
$166.00
Est. +18%
|
$140.65 | - | - |
$253.30
+80.1%
|